These findings suggest that the absence or inhibition of PD-1 can weaken the lineage stability and metabolic adaptability of Tregs in TIME by reducing Foxp3 expression, thereby enhancing anti-tumor immunity [105–107]. The gene discussed is PDCD1; the disease is neoplasm.